Journal Club - Recent Additions

August - 2020

Previous Next    

Showing Journal 4 of 5

Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19

C Spinner, R Gottlieb, G Criner, etal JAMA, 2020, online August 2020


We have seen benefits of remdesivir in patients with severe COVID-19 in terms of time clinical improvement. 


We have seen;

  • Open label RCT remdesivir for 5-days vs 10-days in hospitalised COVID-19 with hypoxia


Previous Comments

No Comments yet.